A NEW PROMISING DRUG FOR ALZHEIMER’S — OPPORTUNITY FOR INVESTORS
Alzheimer’s
Alzheimer’s is a terrible disease. A new patient is diagnosed with Alzheimer’s in the United States every 65 seconds. More than 5.8 million Americans are living with Alzheimer’s. For those who are over 65, one in 10 has Alzheimer’s dementia.
There is no cure. Now a new treatment is on the horizon. If the treatment works, can you imagine the investment potential?
New Drug
FDA Advisory Committee panel sees ‘substantial evidence’ for approval of Alzheimer’s drug from Biogen (BIIB). BIIB is in the Arora Report Portfolio.
We previously wrote:
… Please click here or the title below to read more.If the drug ultimately works and is approved, BIIB may ultimately exceed $2,000.
November 5, 2020